Noninvasive IBS Testing Linked to Fewer Procedures and Lower Diagnostic Costs
A study found that use of IBS-Smart and Trio-Smart tests was linked to fewer colonoscopies and lower diagnostic costs among adults with suspected irritable bowel syndrome.
A study found that use of IBS-Smart and Trio-Smart tests was linked to fewer colonoscopies and lower diagnostic costs among adults with suspected irritable bowel syndrome.
A new study presented at ADLM 2026 shows a high-sensitivity biosensor can quantify the ESAT-6 protein in blood, distinguishing active tuberculosis from latent infection and other lung diseases.
The NIH has awarded $1.3 million to UMass Amherst’s Chang Liu to develop an at-home HIV test with lab-comparable sensitivity, aiming to improve early diagnosis and address diagnostic barriers in resource-limited settings.
WHO has added the first molecular diagnostic test for Ebola Bundibugyo virus to its Emergency Use Listing, aiming to support rapid infection confirmation and surveillance during the ongoing outbreak in Central Africa.
The system simultaneously detects RSV, influenza A and B, and SARS-CoV-2 from a nasal swab in under 10 minutes.
The new molecular panels are designed to detect up to 22 pathogens in one hour with enhanced norovirus detection.
A randomized trial found Cepheid’s Xpert Xpress MVP test improved appropriate treatment rates for vaginitis within 24 hours compared to standard diagnostic methods.